Access cutting-edge lung cancer treatment through this clinical trial at a research site in Jersey City. Study-provided care at no cost to qualified participants.
Access lung cancer specialists in Jersey City at no cost
This study follows strict safety protocols and ethical guidelines
All study-related lung cancer treatment provided free
The purpose of the research is to evaluate a new schedule of alternating cycles of induction chemoimmunotherapy (chemotherapy plus pembrolizumab) and immunotherapy (pembrolizumab) alone for the initial treatment of patients with advanced lung or head and neck cancers.
Sponsor: Rutgers, The State University of New Jersey
Check if you qualify for this lung cancer clinical trial in Jersey City, NJ
If you're searching for lung cancer treatment options in Jersey City, NJ, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Jersey City research site is actively enrolling participants for this clinical trial. You'll receive care from experienced lung cancer specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.